Drägerwerk AG & Co. KGaA specializes in medical and safety technology, with a strong presence in Europe and North America. The company is known for its advanced respiratory and anesthesia equipment, which are critical in hospitals and emergency services, driving consistent demand and revenue stability.
Business Overview
Drägerwerk generates revenue primarily through the sale of medical devices, including ventilators, anesthesia machines, and patient monitoring systems. Its competitive advantages include a strong brand reputation, extensive R&D capabilities, and a global distribution network that enhances pricing power.
Changes in hospital spending on medical devices, particularly in Europe and North America
Regulatory approvals for new medical technologies
Market demand for respiratory care products, especially post-pandemic
Currency fluctuations impacting international sales
Risk Factors
Technological disruption from emerging medical technologies
Regulatory changes affecting product approvals and market access
Intense competition from other medical device manufacturers like Philips and GE Healthcare
Potential for price erosion in key product categories
Low liquidity risk due to a current ratio of 2.07
Potential pension obligations impacting cash flow
Macro Sensitivity
moderate - As a healthcare provider, Drägerwerk's revenue is somewhat insulated from economic downturns, but hospital budgets can be affected by broader economic conditions.
Low - The company has low debt levels (Debt/Equity of 0.14), minimizing the impact of rising interest rates on financing costs.
minimal - Drägerwerk's operations are not heavily reliant on credit markets, given its strong cash flow and low debt.
Profile
value - Investors may be drawn to Drägerwerk's low valuation multiples (P/S of 0.5x) and solid cash flow generation.
low - The stock has shown stable returns with a historical beta below 1.0, indicating lower volatility relative to the market.
Explore More
Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
